Global Artificial Organs Market

Focus on Organ Type, Technology Type, Competitive Landscape, Pipeline Products Data, and 12 Countries Data - Analysis and Forecast, 2018-2023

Published Year: 2018
SKU: BH00668SA

5000

Online Access for One Person. Permission to Print

A quick peek into the report

Table of Contents

Download this TOC  

Request a Sample

1 Market Overview

          1.1    Introduction
          1.2    Transplantation and Rising Need for Artificial Organs
          1.3    The Widening Gap between Demand and Supply of Organs
          1.4    Advent of Artificial Organs and Current Status
          1.5    Impact of Artificial Organs: Advantages and Disadvantages
          1.6    The Future of Artificial Organs
          1.7    Global Market Scenario
          1.8    Assumptions and Limitations

2 Market Dynamics

          2.1    Overview
          2.2    Impact Analysis
          2.3    Market Drivers
                   2.3.1    Growing Geriatric Population
                   2.3.2    Rising Incidence of Lifestyle Diseases
                   2.3.3    Increasing Need for Organ Transplantation and Substantial Shortage of Available Donors
                   2.3.4    Persistent Support from Government and Non-Governmental Organizations
                   2.3.5    Technological Advancements and Increased R&D Expenditure
          2.4    Challenges
                   2.4.1    Risks of Device Malfunction and Other Related Concerns
                   2.4.2    Immune Barrier to Artificial Organ
                   2.4.3    Stringent Regulation and Poor Reimbursement Coverage
                   2.4.4    Exorbitant Cost of Artificial Organs
          2.5    Opportunities
                   2.5.1    Application of Advanced Biomaterials in Artificial Organs
                   2.5.2    Organ-on-Chips Technology
                   2.5.3    Monitoring Artificial Organs Using Precise Diagnostics

3 Competitive Landscape

          3.1    Key Developments and Strategies
                   3.1.1    Product Approvals
                   3.1.2    Agreements, Collaborations and Partnerships
                   3.1.3    Funding
                   3.1.4    Product Launches and Developments
                   3.1.5    Acquisition
                   3.1.6    Other Strategies
                   3.1.7    Market Share Analysis
                   3.1.8    Growth Share Analysis (by Organ Type)
          3.2    Industry Attractiveness
                   3.2.1    Bargaining Power of Suppliers
                   3.2.2    Bargaining Power of Buyers
                   3.2.3    Threat of New Entrants
                   3.2.4    Threat of Substitute Products
                   3.2.5    Intensity of Competitive Rivalry

4 Regulatory Framework

          4.1    Legal Requirements and Framework at International Level
                   4.1.1    International Federation for Artificial Organs (IFAO)
                   4.1.2    World Health Organization (WHO)
          4.2    Legal Requirements and Framework in the Americas
                   4.2.1    American Society for Artificial Internal Organs (ASAIO)
                   4.2.2    American Society of Transplantation (AST)
                   4.2.3    American Chemical Society (ACS)
                   4.2.4    United States Department of Health and Human Services (HHS)
          4.3    Legal Requirements and Framework in Europe
                   4.3.1    European Society for Artificial Organs (ESAO)
                   4.3.2    European Society of Organ Transplantation (ESOT)
                   4.3.3    British Transplantation Society (BTS)
                   4.3.4    European Society for Bone Marrow and Transplantation (EBMT)
                   4.3.5    European Commission (EC)
          4.4    Legal Requirements and Framework in Asia-Pacific
                   4.4.1    Asia-Pacific Society of Artificial Organs (ASPAO)
                   4.4.2    Organ and Tissue Authority (OTA)
                   4.4.3    Japanese Society for Artificial Organ (JSAO)
                   4.4.4    Society for Biomaterials and Artificial Organs

5 Global Artificial Organs Market (by Organ Type)

          5.1    Overview
          5.2    Artificial Pancreas
          5.3    Artificial Heart
          5.4    Artificial Ear
          5.5    Artificial Eye
          5.6    Artificial Urinary Bladder

6 Global Artificial Organs Market (by Technology)

          6.1    Overview
          6.2    Wearable Technologies
          6.3    Implantable Technologies

7 Global Artificial Organs Market (by Region)

          7.1    Global Artificial Organs Market: Analysis of Growth Potential of Different Countries
          7.2    Global Overview
          7.3    North America
                   7.3.1    The U.S.
                   7.3.2    Canada
          7.4    Europe
                   7.4.1    Germany
                   7.4.2    The U.K.
                   7.4.3    France
                   7.4.4    Italy
                   7.4.5    Sweden
                   7.4.6    Rest-of-Europe
          7.5    Asia-Pacific
                   7.5.1    Japan
                   7.5.2    China
                   7.5.3    Australia
                   7.5.4    India
                   7.5.5    Singapore
                   7.5.6    Rest-of-Asia-Pacific
          7.6    Rest-of-the-World
                   7.6.1    Latin America
                   7.6.2    Middle East & Africa

8 Company Profiles

          8.1    Overview
          8.2    Advanced Bionics AG and affiliates
                   8.2.1    Company Overview
                   8.2.2    Role of Advanced Bionics AG and affiliates in the Artificial Organs Market
                   8.2.3    SWOT Analysis
          8.3    Boston Scientific Corporation
                   8.3.1    Company Overview
                   8.3.2    Role of Boston Scientific Corporation in the Artificial Organs Market
                   8.3.3    Financials
                               8.3.3.1    Key Insights about Financial Health of the Company
                   8.3.4    SWOT Analysis
         8.4    CARMAT
                  8.4.1    Company Overview
                  8.4.2    Role of CARMAT in the Artificial Organs Market
                  8.4.3    SWOT Analysis
         8.5    Cochlear Ltd.
                  8.5.1    Company Overview
                  8.5.2    Role of Cochlear Ltd. in the Artificial Organs Market
                  8.5.3    Financials
                  8.5.4    Key Insights about Financial Health of the Company
                  8.5.5    SWOT Analysis
         8.6    Dexcom, Inc.
                  8.6.1    Company Overview
                  8.6.2    Role of Dexcom, Inc. in the Artificial Organs Market
                  8.6.3    Financials
                  8.6.4    Key Insights about Financial Health of the Company
                  8.6.5    SWOT Analysis
         8.7    Insulet Corporation
                  8.7.1    Company Overview
                  8.7.2    Role of Insulet Corporation in the Artificial Organs Market
                  8.7.3    Financials
                              8.7.3.1    Key Insights about Financial Health of the Company
                  8.7.4    SWOT Analysis
         8.8    KeraMed, Inc.
                  8.8.1    Company Overview
                  8.8.2    Role of KeraMed, Inc. in the Artificial Organs Market
                  8.8.3    SWOT Analysis
         8.9    MED-EL
                  8.9.1    Company Overview
                  8.9.2    Role of MED-EL in the Artificial Organs Market
                  8.9.3    SWOT Analysis
        8.10   Medtronic plc
                  8.10.1    Company Overview
                  8.10.2    Role of Medtronic plc in the Artificial Organs Market
                  8.10.3    Financials
                                8.10.3.1    Key Insights about Financial Health of the Company
                  8.10.4    SWOT Analysis
        8.11   Oticon Medical
                  8.11.1    Company Overview
                  8.11.2    Role of Oticon Medical in the Artificial Organs Market
                  8.11.3    SWOT Analysis
        8.12   PIXIUM VISION
                  8.12.1    Company Overview
                  8.12.2    Role of PIXIUM VISION in the Artificial Organs Market
                  8.12.3    SWOT Analysis
        8.13   Retina Implant AG
                  8.13.1    Company Overview
                  8.13.2    Role of Retina Implant AG in the Artificial Organs Market
                  8.13.3    SWOT Analysis
        8.14   Second Sight Medical Products, Inc.
                  8.14.1    Company Overview
                  8.14.2    Role of Second Sight Medical Products, Inc. in the Artificial Organs Market
                  8.14.3    Financials
                                8.14.3.1    Key Insights about Financial Health of the Company
                  8.14.4    SWOT Analysis
        8.15   SynCardia Systems, LLC
                  8.15.1    Company Overview
                  8.15.2    Role of SynCardia Systems, LLC in the Artificial Organs Market
                  8.15.3    SWOT Analysis
        8.16   Tandem Diabetes Care, Inc.
                  8.16.1    Company Overview
                  8.16.2    Role of Tandem Diabetes Care, Inc. in the Artificial Organs Market
                  8.16.3    Financials
                                8.16.3.1    Key Insights about Financial Health of the Company
                  8.16.4    SWOT Analysis

9 Research Scope and Methodology

          9.1    Report Scope
          9.2    Global Artificial Organs Market: Research Methodology

List of Tables

Table: 1    Global Artificial Organs Market, 2017 and 2023
Table: 1.1    Total Number of Donors in Different Countries in 2015 [Data presented in absolute number and rate per million inhabitants (pmp)]
Table: 1.2    Total Number of Organ Transplantation (Tx) in Different Countries in 2015 [Data presented in absolute number and rate per million inhabitants (pmp)]
Table: 2.1    Impact Analysis of Market Drivers
Table: 2.2    Impact Analysis of Market Challenges
Table: 2.3    Percentage of Total Regional Population Aged 65 Years & Above: 2015 & 2030
Table: 2.4    Contribution of Risk Factors to Lifestyle Diseases (Percentage of Individual Population Attributable Fraction)
Table: 2.5    Disease Burden Due to Common Lifestyle Diseases across Different Regions, 2016
Table: 2.6    Funding Initiatives by Government and Research institutes
Table: 2.7    Funding Initiatives by Private and Public Companies
Table: 2.8    Research and Development Expenses in 2016 and 2017 ($Million)
Table: 2.9    Post-Operational Consequences of SynCardia TAH Implantation
Table: 2.10    Post-Operational Consequences of Total Artificial Heart (TAH) Implantation
Table: 4.1    Regulatory Authorities/Associations/Consortiums for Medical Devices in the Americas
Table: 4.2    Regulatory Authorities/Associations/Consortiums for Medical Devices in Europe
Table: 4.3    Regulatory authorities/associations/consortiums for Medical Devices in Asia-Pacific
Table: 5.1    Pipeline Products of Artificial Pancreas
Table: 5.2    List of Companies and Product Offerings in Artificial Organs Market (by Ear)
Table: 5.3    List of Companies and Product Offerings in Artificial Organs Market (by Eye)
Table: 5.4    Pipeline Products of Artificial Eye
Table: 6.1    List of Artificial Organs with Wearable Technologies
Table: 6.2    List of Artificial Organs with Implantable Technologies

List of Figures

Figure: 1    Types of Artificial Organs
Figure: 2    Global Artificial Organs Market Snapshot
Figure: 3    Impact of Market Drivers and Market Restraints, 2017
Figure: 4    Share of Key Developments and Strategies, January 2014-August 2018
Figure: 5    Market Share of Key Companies, 2016 and 2017
Figure: 6    Global Artificial Organs Market Share (by Organ Type), 2017-2023
Figure: 7    Global Artificial Organs Market Share (by Technology Type), 2017-2023
Figure: 8    Global Artificial Organs Market Share (by Region), 2017 and 2023
Figure: 1.1    Factors Playing Significant Role in Demand and Supply of Organs
Figure: 1.2    Evolution of Artificial Organs
Figure: 1.3    Advantages and Disadvantages of Artificial Organs
Figure: 1.4    Global Artificial Organs Market, 2017-2023
Figure: 2.1    Market Dynamics
Figure: 2.2    Projected Global Geriatric Population Aged 60 Years and Above (Billion), 1900-2100
Figure: 2.3    Number of Donors Recovered and Patients Waiting at the Year-end vs. Number of Transplants Performed, 2010-2017
Figure: 2.4    Function of Multi Organs-on-Chips
Figure: 3.1    Competitive Landscape (January 2010-October 2018)
Figure: 3.2    Share of Key Developments and Strategies, January 2014-August 2018
Figure: 3.3    Product Approvals (by Company), January 2010-August 2018
Figure: 3.4    Agreements, Collaborations, and Partnerships (by Company), January 2010-August 2018
Figure: 3.5    Funding Activities (by Company), January 2010-August 2018
Figure: 3.6    Product Launches and Developments (by Company), January 2010-August 2018
Figure: 3.7    Acquisitions (by Company), January 2010-August 2018
Figure: 3.8    Market Share Analysis for Global Artificial Organs Market, 2016
Figure: 3.9    Market Share Analysis for Global Artificial Organs Market, 2017
Figure: 3.10    Growth Share Matrix for Global Artificial Organs Market (by Organ Type), 2017
Figure: 3.11    Bargaining Power of Suppliers: Overall Impact
Figure: 3.12    Bargaining Power of Buyers: Overall Impact
Figure: 3.13    Threat of New Entrants: Overall Impact
Figure: 3.14    Threat of Substitute Products: Overall Impact
Figure: 3.15    Intensity of Competitive Rivalry: Overall Impact
Figure: 5.1    Artificial Organs Market Segmentation (by Organ Type)
Figure: 5.2    Global Artificial Organs Market (by Organ Type), 2017-2023
Figure: 5.3    Mechanism of Action of Artificial Pancreas
Figure: 5.4    Global Artificial Organs Market (by Pancreas), 2017-2023
Figure: 5.5    Revenue Forecast of Companies with Artificial Pancreas in Pipeline, 2019-2023
Figure: 5.6    Mechanism of Action of TAH
Figure: 5.7    Key Points about AbioCor
Figure: 5.8    Global Artificial Organs Market (by Heart), 2017-2023
Figure: 5.9    Sales of SynCardia System, LLC’s TAH (by Volume), 2009-2023
Figure: 5.10    Mechanism of Action of Cochlear Implants
Figure: 5.11    Global Artificial Organs Market (by Ear), 2017-2023
Figure: 5.12    Mechanism of Action of Artificial Retina
Figure: 5.13    Global Artificial Organs Market (by Eye), 2017-2023
Figure: 5.14    Key Points on AMS 800 Urinary Control System
Figure: 5.15    Global Artificial Organs Market (by Urinary Bladder), 2017-2023
Figure: 6.1    Artificial Organs Market Segmentation (by Technology)
Figure: 6.2    Global Artificial Organs Market (by Technology), 2017-2023
Figure: 6.3    Global Artificial Organs Market (by Wearable Technologies), 2017-2023
Figure: 6.4    Global Wearable Artificial Organs Market (by Organ Types), 2017-2023
Figure: 6.5    Global Artificial Organs Market (by Implantable Technologies), 2017-2023
Figure: 6.6    Global Implantable Artificial Organs Market (by Organ Type), 2017-2023
Figure: 7.1    Contribution of Different Artificial Organs in Different Geographical Regions, 2017
Figure: 7.2    Artificial Pancreas: Analysis of Potential Growth Factors Across Different Regions
Figure: 7.3    Artificial Heart: Analysis of Potential Growth Factors across Different Regions
Figure: 7.4    Artificial Eye and Artificial Ear: Analysis of Potential Growth Factors across Different Regions
Figure: 7.5    Global Artificial Organs Market (by Region), 2017 and 2023
Figure: 7.6    North America: Artificial Organs Market, 2017-2023
Figure: 7.7    North America: Market Dynamics
Figure: 7.8    North America: Artificial Organs Market (by Country), 2017-2023
Figure: 7.9    Number of Donors Recovered and Transplants Performed per Year vs. Patients Waiting at Year End
Figure: 7.10    The U.S.: Artificial Organs Market, 2017-2023
Figure: 7.11    Canada: Artificial Organs Market, 2017-2023
Figure: 7.12    Europe: Artificial Organs Market, 2017-2023
Figure: 7.13    Europe: Market Dynamics
Figure: 7.14    Europe: Artificial Organs Market (by Country), 2017-2023
Figure: 7.15    Germany: Artificial Organs Market, 2017-2023
Figure: 7.16    The U.K.: Artificial Organs Market, 2017-2023
Figure: 7.17    France: Artificial Organs Market, 2017-2023
Figure: 7.18    Number of Patients on an Organ Donation Waiting List in Italy in 2017
Figure: 7.19    Italy: Artificial Organs Market, 2017-2023
Figure: 7.20    Sweden: Artificial Organs Market, 2017-2023
Figure: 7.21    Rest-of-Europe: Artificial Organs Market, 2017-2023
Figure: 7.22    Asia-Pacific: Artificial Organs Market, 2017-2023
Figure: 7.23    Asia-Pacific: Market Dynamics
Figure: 7.24    Asia-Pacific: Artificial Organs Market (by Country), 2017-2023
Figure: 7.25    Japan: Artificial Organs Market, 2017-2023
Figure: 7.26    China: Artificial Organs Market, 2017-2023
Figure: 7.27    Australia: Artificial Organs Market, 2017-2023
Figure: 7.28    India: Artificial Organs Market, 2017-2023
Figure: 7.29    Singapore: Artificial Organs Market, 2017-2023
Figure: 7.30    Rest of Asia-Pacific: Artificial Organs Market, 2017-2023
Figure: 7.31    Rest-of-the-World: Artificial Organs Market, 2017-2023
Figure: 7.32    Rest-of-the-World: Market Dynamics
Figure: 7.33    Rest-of-the-World: Artificial Organs Market (by Region), 2017-2023
Figure: 7.34    Latin-America: Artificial Organs Market, 2017-2023
Figure: 7.35    Middle-East and Africa: Artificial Organs Market, 2017-2023
Figure: 8.1    Shares of Key Company Profiles
Figure: 8.2    Advanced Bionics AG and affiliates Product Portfolio for Artificial Organs Market
Figure: 8.3    Advanced Bionics AG and affiliates: SWOT Analysis
Figure: 8.4    Boston Scientific Corporation: Product Portfolio for Artificial Organs Market
Figure: 8.5    Boston Scientific Corporation: Overall Financials, 2015-2017
Figure: 8.6    Boston Scientific Corporation: Revenue (by Segment), 2015-2017
Figure: 8.7    Boston Scientific Corporation: Revenue (by Region), 2015-2017
Figure: 8.8    Boston Scientific Corporation: R&D Expenditure (2015-2017)
Figure: 8.9    Boston Scientific Corporation: Revenue Forecast, 2014-2020
Figure: 8.10    Boston Scientific Corporation: SWOT Analysis
Figure: 8.11    CARMAT Product Portfolio for Artificial Organs Market
Figure: 8.12    CARMAT: SWOT Analysis
Figure: 8.13    Cochlear Ltd.: Product Portfolio for Artificial Organs Market
Figure: 8.14    Cochlear Ltd.: Overall Financials, 2016-2018
Figure: 8.15    Cochlear Ltd.: Revenue (by Segment), 2016-2018
Figure: 8.16    Cochlear Ltd.: Revenue (by Region), 2016-2018
Figure: 8.17    Cochlear Ltd.: R&D Expenditure
Figure: 8.18    Cochlear Ltd.: Revenue Forecast, 2015-2020
Figure: 8.19    Cochlear Ltd.: SWOT Analysis
Figure: 8.20    Dexcom, Inc.: Product Portfolio for Artificial Organs Market
Figure: 8.21    Dexcom, Inc.: Overall Financials, 2015-2017
Figure: 8.22    Dexcom, Inc.: Revenue (by Region), 2015-2017
Figure: 8.23    Dexcom, Inc.: R&D Expenditure (2015-2017)
Figure: 8.24    Dexcom, Inc.: Revenue Forecast, 2014-2020
Figure: 8.25    Dexcom, Inc.: SWOT Analysis
Figure: 8.26    Insulet Corporation: Product Portfolio for Artificial Organs Market
Figure: 8.27    Insulet Corporation: Overall Financials, 2015-2017
Figure: 8.28    Insulet Corporation: Revenue (by Region), 2015-2017
Figure: 8.29    Insulet Corporation: R&D Expenditure (2015-2017)
Figure: 8.30    Insulet Corporation: Revenue Forecast, 2014-2020
Figure: 8.31    Insulet Corporation: SWOT Analysis
Figure: 8.32    KeraMed, Inc. Product Portfolio for Artificial Organs Market
Figure: 8.33    KeraMed, Inc.: SWOT Analysis
Figure: 8.34    MED-EL Product Portfolio for Artificial Organs Market
Figure: 8.35    MED-EL: SWOT Analysis
Figure: 8.36    Medtronic plc: Product Portfolio for Artificial Organs Market
Figure: 8.37    Medtronic plc: Overall Financials, 2016-2018
Figure: 8.38    Medtronic plc: Revenue (by Segment), 2016-2018
Figure: 8.39    Medtronic plc: Revenue (by Region), 2016-2018
Figure: 8.40    Medtronic plc: R&D Expenditure
Figure: 8.41    Medtronic plc: Revenue Forecast, 2015-2020
Figure: 8.42    Medtronic plc: SWOT Analysis
Figure: 8.43    Oticon Medical Product Portfolio for Artificial Organs Market
Figure: 8.44    Oticon Medical: SWOT Analysis
Figure: 8.45    PIXIUM VISION Product Portfolio for Artificial Organs Market
Figure: 8.46    PIXIUM VISION: SWOT Analysis
Figure: 8.47    Retina Implant AG Product Portfolio for Artificial Organs Market
Figure: 8.48    Retina Implant AG: SWOT Analysis
Figure: 8.49    Second Sight Medical Products, Inc.: Product Portfolio for Artificial Organs Market
Figure: 8.50    Second Sight Medical Products, Inc.: Overall Financials, 2016-2018
Figure: 8.51    Second Sight Medical Products, Inc.: Revenue (by Region), 2016-2018
Figure: 8.52    Second Sight Medical Products, Inc.: R&D Expenditure
Figure: 8.53    Second Sight Medical Products, Inc.: SWOT Analysis
Figure: 8.54    SynCardia Systems, LLC Product Portfolio for Artificial Organs Market
Figure: 8.55    SynCardia Systems, LLC: SWOT Analysis
Figure: 8.56    Tandem Diabetes Care, Inc. Product Portfolio for Artificial Organs Market
Figure: 8.57    Tandem Diabetes Care, Inc.: Overall Financials, 2015-2017
Figure: 8.58    Tandem Diabetes Care, Inc.: R&D Expenditure (2015-2017)
Figure: 8.59    Tandem Diabetes Care, Inc.: Revenue Forecast, 2014-2020
Figure: 8.60    Tandem Diabetes Care, Inc.: SWOT Analysis
Figure: 9.1    Global Artificial Organs Market Segmentation
Figure: 9.2    Global Artificial Organs Market Research Methodology
Figure: 9.3    Primary Research
Figure: 9.4    Secondary Research
Figure: 9.5    Data Triangulation
Figure: 9.6    Bottom-up Approach (Segment-wise Analysis)
Figure: 9.7    Top-down Approach (Segment-wise Analysis)
Figure: 9.8    Assumptions and Limitations
Figure: 9.9    Considered Factors for Data Prediction and Modelling

You may also like

Published Year: 2017

Global Next Generation Implants (NGI) Market – Analysis and Forecast (2017-2023): (Focus on Countr

The global next generation implants market is estimated to grow over $3.9 billion by 2023. On...

 
Published Year: 2017

Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market - Analysis and Forecast,

The global pacemakers and ICDs market are expected to grow at a CAGR of 4.6% and 4.8% from...

 

Global Artificial Organs Market

Focus on Organ Type, Technology Type, Competitive Landscape, Pipeline Products Data, and 12 Countries Data - Analysis and Forecast, 2018-2023